We are live on ! Find out more
REPL icon

Replimune Group

78 hedge funds and large institutions have $612M invested in Replimune Group in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 37 increasing their positions, 18 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

106% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 18

1% more funds holding

Funds holding: 7778 (+1)

8% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 12

3% less capital invested

Capital invested by funds: $631M → $612M (-$19.1M)

3.09% less ownership

Funds ownership: 69.12%66.02% (-3.1%)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
78
Holders Change
+1
Holders Change %
+1.3%
% of All Funds
1.57%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.06%
New
13
Increased
37
Reduced
18
Closed
12
Calls
Puts
Net Calls
Net Calls Change

REPL Hedge Fund Activity: Q3 2020 in Review

78 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q3 2020, worth a combined $612M — down 3% from $631M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new REPL positions and 12 closed out — a net gain of 1 holder — while 37 added to existing stakes and 18 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $22.5M. The largest seller was BVF Inc, cutting an estimated $14.2M.

  • 78 institutional investors held Replimune Group (REPL) as of Q3 2020, up from 77 in Q2 2020.
  • Funds reported $612M of Replimune Group stock for Q3 2020, down 3% quarter-over-quarter.
  • 13 funds opened new Replimune Group positions in Q3 2020 and 12 closed out, a net change of +1 holder.
  • The largest Replimune Group buyer in Q3 2020 was Point72 Asset Management, an estimated $22.5M added.
  • The largest Replimune Group seller in Q3 2020 was BVF Inc, an estimated $14.2M sold.

Based on aggregated 13F filings for Q3 2020.